Literatur
- 1
Barret J P, Dziewulski P, Ramzy P I, Wolf S E, Desai M H, Herndon D N.
Biobrane versus 1 % silver sulfadiazine in second degree pediatric burns.
Plast Reconstr Surg.
2000;
105
62-65
- 2
Deitch E A, Wheelahan T M, Rose M P, Clothier J, Cotter J.
Hypertrophic burn scars: analysis of variables.
J Traum.
1983;
23
895-898
- 3
Fishman J A, Patience C.
Xenotransplantation: infectious risk revisited.
Am J Transplant.
2004;
4
1383-1390
- 4
Gerding R L, Imbembo A L, Fratianne R B.
Biosynthetic skin substitute vs. 1 % silver sulfadiazine for the treatment of inpatient
partial-thickness thermal burns.
J Trauma.
1988;
28
1265-1269
- 5
Kealey G P, Aguiar J, Lewis I IRW, Rosenquist M D, Strauss R G, Bale Jr J F.
Cadaver skin allografts and transmission of human cytomegalovirus to burn patients.
J Am Coll Surg.
1996;
182
201-205
Prof. Dr. med. Hans-Oliver Rennekampff
Klinik für Plastische, Hand- und Wiederherstellungschirurgie
Medizinische Hochschule Hannover
Carl-Neuberg-Straße 1
30625 Hannover
eMail: phw@mh-hannover.de
